- About Us
- News&Media
- Pipeline
- Products
- Product Features
- PTS302 NSCLC-SMAO
- PTS100 HCC
- PTS-02 ACC
- PTS500 MPE
- Anti-tumor drug for canine use
- DM
- Introduction of PTS Trial Drugs and Core Technology of "Minimally Invasive Targeted Tumor Ablation"
- History of Animal Clinical Trials
- Case Acceptance Indications
- Superficial malignant tumor in canine
- Malignant melanoma of the canine
- Lipoma of the canine and feline
- Malignant bladder tumor of the canine and feline
- Video
- R & D
- Investors
- Youtube
- Contact